4//SEC Filing
Wolin Steven 4
Accession 0001562180-24-008104
CIK 0001568651other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 4:16 PM ET
Size
33.8 KB
Accession
0001562180-24-008104
Insider Transaction Report
Form 4
Wolin Steven
Chief Operating Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2024-12-01+1,483→ 91,230 total - Exercise/Conversion
Class A Common Stock
2024-12-01+2,920→ 120,718 total - Exercise/Conversion
Class A Common Stock
2024-12-01+6,033→ 89,747 total - Exercise/Conversion
Class A Common Stock
2024-12-01+1,897→ 93,127 total - Sale
Class A Common Stock
2024-12-02$18.48/sh−353$6,523→ 102,598 total - Exercise/Conversion
Restricted Stock Units
2024-12-01−2,920→ 26,282 total→ Class A Common Stock (2,920 underlying) - Exercise/Conversion
Restricted Stock Units
2024-12-01−1,460→ 13,141 total→ Class A Common Stock (1,460 underlying) - Exercise/Conversion
Restricted Stock Units
2024-12-01−24,671→ 123,356 total→ Class A Common Stock (24,671 underlying) - Exercise/Conversion
Class A Common Stock
2024-12-01+24,671→ 117,798 total - Exercise/Conversion
Class A Common Stock
2024-12-01+1,460→ 122,178 total - Sale
Class A Common Stock
2024-12-02$18.07/sh−19,227$347,432→ 102,951 total - Exercise/Conversion
Restricted Stock Units
2024-12-01−6,033→ 6,034 total→ Class A Common Stock (6,033 underlying) - Exercise/Conversion
Restricted Stock Units
2024-12-01−1,483→ 1,483 total→ Class A Common Stock (1,483 underlying) - Exercise/Conversion
Restricted Stock Units
2024-12-01−1,897→ 1,897 total→ Class A Common Stock (1,897 underlying)
Footnotes (7)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.46 to $18.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.46 to $18.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F5]The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning June 1, 2022.
- [F6]The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning June 1, 2023.
- [F7]The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning June 1, 2024.
Documents
Issuer
Oscar Health, Inc.
CIK 0001568651
Entity typeother
Related Parties
1- filerCIK 0002021524
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 4:16 PM ET
- Size
- 33.8 KB